What the FDA Says… and What the Company Hears

Biocom is reprising this popular discussion on communicating successfully with the Food and Drug Administration. This will be a highly interactive session discussing the challenges and opportunities of dealing with the FDA, both from a company perspective and the perspective of those who have been on the reviewer side of the table. More information and online registration is here.